Journal article
A Unique Dual-Readout High-Throughput Screening Assay To Identify Antifungal Compounds with Aspergillus fumigatus
mSphere, Vol.6(4), pp.1-15
08/25/2021
DOI: 10.1128/mSphere.00539-21
PMCID: PMC8386399
PMID: 34406854
Abstract
Fungal infections caused by molds have the highest mortality rates of human fungal infections. These devastating infections are hard to treat and available antifungal drugs are often not effective.
ABSTRACT
Treatment of invasive mold infections is limited by the lack of adequate drug options that are effective against these fatal infections. High-throughput screening of molds using traditional antifungal assays of growth is problematic and has greatly limited our ability to identify new mold-active agents. Here, we present a high-throughput screening platform for use with
Aspergillus fumigatus
, the most common causative agent of invasive mold infections, for the discovery of novel mold-active antifungals. This assay detects cell lysis through the release of the cytosolic enzyme adenylate kinase and, thus, is not dependent on changes in biomass or metabolism to detect antifungal activity. The ability to specifically detect cell lysis is a unique aspect of this assay that allows identification of molecules that disrupt fungal cell integrity, such as cell wall-active molecules. We also found that germinating
A. fumigatus
conidia release low levels of adenylate kinase and that a reduction in this background allowed us to identify molecules that inhibit conidial germination, expanding the potential for discovery of novel antifungal compounds. Here, we describe the validation of this assay and proof-of-concept pilot screens that identified a novel antifungal compound, PIK-75, that disrupts cell wall integrity. This screening assay provides a novel platform for high-throughput screens with
A. fumigatus
for the identification of anti-mold drugs.
IMPORTANCE
Fungal infections caused by molds have the highest mortality rates of human fungal infections. These devastating infections are hard to treat and available antifungal drugs are often not effective. Therefore, the identification of new antifungal drugs with mold activity is critical. Drug screening with molds is challenging and there are limited assays available to identify new antifungal compounds directly with these organisms. Here, we present an assay suitable for use for high-throughput screening with a common mold pathogen. This assay has exciting future potential for the identification of new drugs to treat these fatal infections.
Details
- Title: Subtitle
- A Unique Dual-Readout High-Throughput Screening Assay To Identify Antifungal Compounds with Aspergillus fumigatus
- Creators
- Sarah R. Beattie - University of IowaDamian J. Krysan - Roy J. and Lucille A. Carver College of Medicine
- Contributors
- David S. Perlin (Editor)
- Resource Type
- Journal article
- Publication Details
- mSphere, Vol.6(4), pp.1-15
- DOI
- 10.1128/mSphere.00539-21
- PMID
- 34406854
- PMCID
- PMC8386399
- ISSN
- 2379-5042
- eISSN
- 2379-5042
- Grant note
- DOI: 10.13039/100000002, name: HHS | National Institutes of Health, award: 5F32AI145160
- Language
- English
- Date published
- 08/25/2021
- Academic Unit
- Microbiology and Immunology; Stead Family Department of Pediatrics; Infectious Disease (Pediatrics)
- Record Identifier
- 9984297424502771
Metrics
13 Record Views